Photo of Bhanu K. Sadasivan, PhD

Bhanu K. Sadasivan, PhD, focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software. Read Bhanu K. Sadasivan's full bio. 

Addressing the disclosure-dedication doctrine, the US Court of Appeals for the Federal Circuit concluded that the disclosure-dedication doctrine barred a patent owner’s claim of infringement under the doctrine of equivalents because the asserted patents disclose, but do not claim, the alleged equivalent. Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC, Case No. 19-1924 (Fed. Cir. May 8, 2020) (Reyna, J.).

Continue Reading Court’s Drug Patent Prescription: Unclaimed Disclosure is Dedicated